eyenovia
report
third
quarter
results
tuesday
november
new
york
globe
newswire
eyenovia
nasdaq
eyen
clinical
stage
ophthalmic
biopharmaceutical
company
developing
pipeline
microdose
array
print
therapeutics
today
announced
company
release
financial
results
third
quarter
ended
september
tuesday
november
market
close
following
release
eyenovia
chief
executive
officer
chief
medical
officer
sean
ianchulev
chief
financial
officer
john
gandolfo
vice
president
commercial
michael
rowe
host
conference
call
review
financial
operating
results
conference
call
scheduled
begin
pm
et
tuesday
november
participants
dial
domestic
international
conference
code
live
webcast
conference
call
also
available
investor
relations
page
company
corporate
website
live
webcast
event
archived
eyenovia
website
one
year
eyenovia
eyenovia
nasdaq
eyen
clinical
stage
ophthalmic
biopharmaceutical
company
developing
pipeline
microdose
array
print
therapeutics
eyenovia
pipeline
currently
focused
development
microdosed
medications
presbyopia
pediatric
myopia
progression
mydriasis
information
please
visit
eyenovia
investor
contacts
john
gandolfo
jgandolfo
eric
ribner
lifesci
advisors
llc
eric
eyenovia
media
contact
diana
soltesz
pazanga
health
communications
dsoltesz
